China Universal Asset Management Company’s PMV Pharmaceuticals PMVP Stock Holding History

China Universal Asset Management Company’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,251	Closed	-$7.68K	–	471
2023 Q3	$7.68K	Buy	1,251 +651	+109%	+$4.48K	﹤0.01%	363
2023 Q2	$3.76K	Sell	600 -18	-3%	-$94	﹤0.01%	395
2023 Q1	$2.95K	Buy	618 +154	+33%	+$1.08K	﹤0.01%	413
2022 Q4	$4.04K	Buy	464 +37	+9%	+$394	﹤0.01%	319
2022 Q3	$5K	Buy	+427	New	+$6.17K	﹤0.01%	274

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

China Universal Asset Management Company's PMVP Position: Q4 2023 in Review

China Universal Asset Management Company sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 1,251 shares — an estimated $7.68K sold.

China Universal Asset Management Company first reported a position in PMVP in Q3 2022 and held it in 5 quarters. The position peaked at $7.68K in Q3 2023. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

China Universal Asset Management Company reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 1,251 PMV Pharmaceuticals shares in Q4 2023, an estimated $7.68K.
China Universal Asset Management Company first reported a position in PMV Pharmaceuticals in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's PMV Pharmaceuticals position peaked at $7.68K in Q3 2023.
98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.